臨床開発ソリューション
Innovating at the speed of change.
Expect safety, quality and speed as we deliver the data package you need to bring your product to market.
Move with speed
In-study agility and real-time information allow us to rapidly react to challenges and recognize opportunities to accelerate your trial.
Connect with sites and patients
With 15,000+ investigators and 5,500+ sites in our network, our advanced patient recruitment engine drives high-speed enrollment.
Apply 30+ years of insights
Our world-class team brings the right mix of full service and FSP during your study and beyond.
Accelerate your product to market
投資が大きな場合、経験豊富なエンドツーエンドのパートナーが必要です。 With your product's future on the line, our approach ensures that your projects are delivered within targets.
You're not merely looking for experts-you want the right team for your study.当社では、お客様独自の研究ニーズと関連の高い、科学・治療面の専門知識を備えた経験豊富なプロジェクト管理チームを提供します。
Insights to drive decision-making
Real-time information helps us move quickly, anticipate risk and uncover opportunities to advance your study. With our distinct combination of digital innovation and data-driven insights, we can eliminate white space and meet critical timelines.
Supporting sites
治験責任医師および分担医師にかかる経費は、研究総予算のほぼ半分を占めることがあります。 Fortrea's global processes deliver efficient, timely and accurate invoicing, which helps you stay within 3 percent of your planned budget more than 90 percent of the time.
We will help you find the most appropriate study locations and the most qualified investigators to support target patient enrollment populations.当社独自のインフォマティクスデータベースを使用すれば、初期の段階から目標とする患者様の参加率の達成に貢献する治験責任医師および分担医師を選択できるようになります。
A focus on patients
With a global network of sites and solutions to drive diversity and inclusion in clinical trials and protocol designs that incorporate our Voice of the Patient program, we develop clinical trial strategies that can be achieved with patients motivated to participate.
Invested in your diversity goals
As the U.S. FDA continues to intensify its focus on improving diversity in clinical trials, we are actively helping sponsors prepare their Diversity Action Plans. To date, Fortrea has led the way, completing ~15% of all Diversity Action Plans for the FDA.
We act as an extension of your team to support your diversity goals and inclusion practices in clinical trials. We're also gathering the FDA's feedback to better prepare for studies that will start once approval of a Diversity Action Plan before initiation of pivotal studies is mandated.
